<DOC>
	<DOCNO>NCT01268631</DOCNO>
	<brief_summary>Hypothesis : Response therapy fibromyalgia improve couple specific medication individual pattern dysfunctional pain modulation . Individuals exhibit wide range pain modulate capability assess dynamic psychophysical testing . Those exhibit less efficient endogenous analgesia and/or increase pain summation know prone suffer pain . Tailoring medication compensate specific dysfunctioning modulatory mechanism improve pain control .</brief_summary>
	<brief_title>Mechanism-based Choice Therapy : Can Treatments Success Fibromyalgia Patients Coupled Psychophysical Pain Modulation Profile ?</brief_title>
	<detailed_description>Plan Overview : The study conduct double - blind research . After undergo evaluation pain processing detail protocol , patient recruit randomised receive Douloxetine Pregabalin , two medication evidence - base efficacy treatment fibromyalgia syndrome . After first week study , patient recruit receive active treatment one two medication . This project recruit fibromyalgia patient . Those patient treat either Duloxetine Pregabalin , follow make response treatment well possible change pain modulation . Study population : We plan 40 fibromyalgia patient complete analgesic treatment phase two medication . Considering expect drop 30-50 % , 150 patient recruit . Inclusion criterion : fibromyalgia patient . All patient undergo physical examination tender point evaluation ascertain fulfillment ACR 1990 criterion classification fibromyalgia ( Wolfe et al 1990 ) i.e . presence widespread pain last least 3 month presence tenderness least 11 18 tender point . Exclusion criterion : age 18 80 ; patient cognitive dysfunction preclude use psychophysics , communicate Hebrew , abnormal renal function creatinine 1.5 , elevate liver enzymes &gt; x3 upper limit . Since duloxetine potential act substrate inhibitor cytochrome P4502D6 ( CYP2D6 ) inhibiting , caution use CYP2D6 substrates inhibitor ( tricyclic antidepressant SSRIs ) coadministered duloxetine ( Skinner et al. , 2003 ) . Patients currently treat Douloxetine , Pregabalin , Gabapentin , Milnacipran , amitryptiline SSRIs , NSRIs tricyclic medication recruit unless consent discontinue prior medication three week enrolment study . During period use NSAIDS common analgesic medication permit . Patietns currently treat medication recruit . Patietns suffer chronic pain due know active malignancy localize cause ( e.g . fracture , Herpes Zoster etc . ) recruit . Systemic pain modulation : 1 . DNIC assess difference pain rating 'test stimulus ' apply immersion contralateral hand hot water bath ( 'conditioning stimulus ' ) . 'Test stimulus ' 30 '' contact heat stimulus ( 30x30 mm2 thermode , TSA-2001 , Medoc ) deliver non-dominant forearm individually-predetermined temperature evoke pain intensity 60 0-100 NPS ( detail Granot et al. , 2006 ) . The stimulus temperature rise 2oC/sec 32oC destination temperature . Fifteen minute completion first pre-immersion test , patient ask immerse his/her dominant hand 1 ' water bath 46.5oC ( Heto Cooling Bath CBN 8-30 , Allerod , Denemark ) , second application 'test stimulus ' repeat last 30 '' immersion . To assess residual DNIC effect 3 ' end immersion , 'test stimulus ' apply third time . During application 'test stimulus ' patient ask rate thermal pain intensity every 10 ' ( NPS , 4 reading total ) . 2 . Mechanical Temporal Summation ( TS ) assess 6.45mN von Frey filament ( Stoeteling Ltd . US ) . A single stimulus , train 10 successive stimulus apply volar forearm , ISI 1 '' . Pricking pain score ( 0-100 NPS ) obtain single , end train . The difference score calculate TS . Static pain pyschophysics : 1 . Sensory mechanical tactile threshold determine use von Frey filament , volar forearm . Stimuli ascend low filament , subject report clear tactile sensation 2/3 application . 2 . Sensory thermal threshold determine use TSA , volar forearm . Temperature increase decrease patient ask press button perceive temperature warm cold , respectively . 3 . Mechanical pain threshold assess similar , start von Frey 4.88mN volar forearm . 4 . Pain thermal threshold determine use TSA , volar forearm . Temperature increase decrease patient ask press button perceive temperature painful . 3.2.4.4 . Clinical pain assessment Mean maximal pain score last week obtain subject test session . Characteristics pain assess use validate Hebrew version Fibromyalgia Impact questionnaire ( FIQ ) ( Buskila et al 1996 ) . In addition , intensity level pain interfere life assess use Brief Pain Inventory ( BPI ) ( Cleeland &amp; Ryan , 1994 ) well pain catastrophizing level Spielberger state trait anxiety inventory questionnaire . The Pittsburgh sleep quality index ( PSQI ) also assess . The record use analgesic treatment , include use opioids obtain . Pain relief treatment : Our previous experience indicate even within chronic pain patient still wide enough range DNIC TS . Treatments give 6 week , physician administer treatment know treatment give ( code break stage serious adverse event discretion PI ) . Thus patient assess personal blind type therapy . In order evaluate placebo effect , patient , first week treatment administration non-active placebo . All patient proceed active treatment stage , report 50 % pain reduction placebo treatment analyze separately . Some patient , addition describe lab test schedule , invite test experimental pain perception end placebo period . For purpose blinding across treatment , every medication administer twice daily ( use different capsule color morning even tablet ) . The use rescue pain alleviation NSAIDs permit stage . a. Duloxetine . Initial dose 30 mg/d give one week , order minimize possible side effect drop out , fix dose 60 mg/d give additional 4 week . The assess person contact patient phone every week treatment period receive pain score last 24 hour , indication effect among patient discontinue medication . Patients ask visit clinic last week treatment , assessment clinical pain ( questionnaire ) pain modulation . Outcome measure data analysis The primary outcome correlation pain modulation drug effect . This explored stage , relation clinical pain pain variable hyperalgesia . Logistic regression model construct best predict drug effect consider modulation mechanism , time measurement , acute chronic pain . NNTs calculate base modulation state patient ( &gt; 50 % pain relief consider successful treatment ) .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Fibromyalgia patient . All patient undergo physical examination tender point evaluation ascertain fulfillment ACR 1990 criterion classification fibromyalgia ( Wolfe et al 1990 ) i.e . presence widespread pain last least 3 month presence tenderness least 11 18 tender point . Age 18 80 Patients cognitive dysfunction preclude use psychophysics , communicate Hebrew , abnormal renal function creatinine 1.5 , elevate liver enzymes &gt; x3 upper limit . Since duloxetine potential act substrate inhibitor cytochrome P4502D6 ( CYP2D6 ) inhibiting , caution use CYP2D6 substrates inhibitor ( tricyclic antidepressant SSRIs ) coadministered duloxetine ( Skinner et al. , 2003 ) . Patients currently treat Douloxetine , Pregabalin , Gabapentin , Milnacipran , amitryptiline SSRIs , NSRIs tricyclic medication recruit unless consent discontinue prior medication three week enrolment study . During period use NSAIDS common analgesic medication permit . Patients currently treat medication recruit . Patients suffer chronic pain due know active malignancy localize cause ( e.g . fracture , Herpes Zoster etc . ) recruit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>Pain modulation</keyword>
</DOC>